Found 24 matching trials
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure
PHASE2This study evaluates a personalized treatment strategy for patients with la...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
PHASE2To evaluate the efficacy and side effects of Zanubrutinib combined with Obi...
Zanubrutinib Combined With G-CVP in Previously Untreated FL
PHASE2The goal of this clinical trial is to learn the efficacy and safety of zanu...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2The goal of this phase II randomized open label study is to compare the rat...
Location
H. General Univ. de Alicante
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma
PHASE2This clinical study examined the safety and efficacy of the combination of ...
Location
Emory University Winship Cancer Institute
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
PHASE1The purpose of this study is to determine the safety, tolerability; and to ...
Status
Active Not Recruiting
Location
UCLA Hematologyoncology
Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1The purpose of this clinical trial is to learn if the study drug Tazemetost...
Status
Active Not Recruiting
Location
Huntsman Cancer Institute at University of Uta
Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma
PHASE2This study is planned to prospectively evaluates the efficacy and safety of...
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin 300020
The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL
PHASE1A Single-Arm, Prospective Clinical Study Evaluating the Efficacy and Safety...
Location
Shanghai Ruijin Hospital
Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
PHASE1The ZGR regimen limited-course regimen was designed to combine three target...
Status
Active Not Recruiting
Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College